Heather Preston
CIK: 0001606826
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALGS
Aligos Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Preston Heather
Preston Heather (SEC CIK 0001606826) files insider reports with the SEC as Director of Aligos Therapeutics, Inc. (ALGS).
Signal8 holds 2 ownership filings by Preston Heather, all Form 4s, filed between Jun 26, 2025 and Jun 29, 2026. Those filings report 2 transactions, from Jun 25, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Preston Heather's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Preston Heather
Other insiders filing for Aligos Therapeutics, Inc. (ALGS)
- Chavez Margarita, Director
- Martell Bridget A, Director
- Scopa James Paul, Director
- Nuechterlein Carole, Director
- Hirth Peter, Director
- Symons Julian A.